Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Artificial intelligence could reduce drug discovery from years to months, according to Demis Hassabis, CEO of Isomorphic Labs ...

The Drug Discovery Outsourcing Market is set to grow at a 7.2% CAGR, driven by advanced technologies and increased demand for specialized expertise. NEWARK, DE, UNITED STATES, September 11, 2025 ...

Revolutionizing antibiotic discovery through artificial intelligence, halicin shows promise against resistant pathogens with ...

Charles Gibbons of Lachman Consultants and Michael Grischeau of AbbVie stressed AI governance, data integrity, and human ...

A new AI Drug Discovery tool called PDGrapher can predict more accurate drug combinations up to 25 times faster than previous ...

Charles River Laboratories International, Inc. (NYSE: CRL) has recently announced two strategic collaborations across its contract development and manufacturing organization (CDMO), aimed at advancing ...

Artificial Intelligence Accelerates Target Discovery and Clinical Trials Traditional drug development faces challenges of long cycles and high costs, and the involvement of artificial intelligence ...

To perform effectively, agentic AI demands profound permissions, like data, application, and decision rights. A misconfigured ...